Platelets induce endothelial–mesenchymal transition and subsequent fibrogenesis in endometriosis

Dingmin Yan, Yan D, Xishi Liu, Liu X, Xu H, Hong Xu, Sun‐Wei Guo, Sun-Wei Guo, Guo SW
Reproductive BioMedicine Online · 2020 · vol. 41(3) , pp. 500–517 · doi:10.1016/j.rbmo.2020.03.020 · PMID:32709523 · W3024821822
article OA: closed CC0 ⤵ 28 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigates how platelets in endometriosis trigger endothelial-mesenchymal transition and subsequent fibrogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Research questionDo endometriotic lesions undergo endothelial-mesenchymal transition (EndoMT)?DesignLesion samples from 30 patients with ovarian endometriomas and deep endometriosis, and control endometrial tissue samples from 30 women without endometriosis, were analysed. In-vitro experimentation using the human umbilical vein endothelial cell (HUVEC) line were conducted. Immunofluorescence staining and immunohistochemistry analysis using antibodies against endothelial cell and mesenchymal cell markers were conducted. The HUVEC cells were co-cultured with activated platelets or control medium with and without neutralization of TGF-β1 PDGFR, or both. Their morphology, proliferation and expression levels of genes and proteins known to be involved in EndoMT were evaluated, along with their migratory and invasive propensity, contractility and collagen production capability.ResultsThe proportion of CD31 and FSP-1 dual-positive cells in FSP-1+ fibroblasts was 74.7% (±5.4%) in ovarian endometrioma lesions, significantly higher than that in deep endometriosis lesions (26.8% ± 26.0%; P = 5.7 × 10-5), and was zero in normal endometrium. The extent of lesional fibrosis correlated positively with staining levels of the lesional mesenchymal markers FSP-1 and α-SMA (r = 0.91; P < 2.2 × 10-16, r = 0.81; P = 5.8 × 10-15, respectively). Human endothelial cells co-cultured with activated platelets acquire a morphology suggestive of EndoMT, concomitant with increased proliferation, loss of CD31 but marked increase in expression of mesenchymal markers. Morphological and gene and protein expression changes are accompanied by functional differentiation reflected by increased migratory and invasive capacity, contractility and collagen production. Neutralization of TGF-β1 and PDGFR signalling abolished platelet-induced EndoMT in human endothelial cells.ConclusionsMultiple sources of myofibroblasts exist in endometriotic lesions, and implicates platelets, EndoMT, or both, as potential therapeutic targets for treating endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Blood Platelets Endometriosis Epithelial-Mesenchymal Transition Fibroblasts Ovarian Diseases Ovary Peritoneal Diseases Adult Cell Transdifferentiation Cell Transdifferentiation Endometriosis Endothelial Cells Endothelial Cells Epithelial-Mesenchymal Transition Female Fibroblasts Fibrosis Fibrosis Humans Human Umbilical Vein Endothelial Cells

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (28)

Source provenance

europepmc
last seen: 2026-08-09T06:10:49.860119+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:47.975235+00:00
License: CC0 · commercial use OK